|
注册号: Registration number: |
ChiCTR2400088028 |
|
最近更新日期: Date of Last Refreshed on: |
2024-08-09 10:41:02 |
|
注册时间: Date of Registration: |
2024-08-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
义齿稳固剂对老年人活动义齿固位稳定性及生活质量的影响 |
|
Public title: |
The effect of denture adhesive on the stability of removable denture and the quality of life in elderly people |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
义齿稳固剂对老年人活动义齿固位稳定性及生活质量的影响 |
|
Scientific title: |
The effect of denture adhesive on the stability of removable denture and the quality of life in elderly people |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王梦琳 |
研究负责人: |
王梦琳 |
|
Applicant: |
Wang Menglin |
Study leader: |
Wang Menglin |
|
申请注册联系人电话: Applicant telephone: |
+86 155 3071 9993 |
研究负责人电话:
Study leader's |
+86 155 3071 9993 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
betty7610wml@163.com |
研究负责人电子邮件: Study leader's E-mail: |
betty7610wml@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市朝阳区工体南路8号 |
研究负责人通讯地址: |
北京市朝阳区工体南路8号 |
|
Applicant address: |
Gongti South Road 8th, Chaoyang District, Beijing |
Study leader's address: |
Gongti South Road 8th, Chaoyang District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京朝阳医院 |
||
|
Applicant's institution: |
Beijing Chaoyang Hospital |
||
|
研究负责人所在单位: |
北京朝阳医院 |
||
|
Affiliation of the Leader: |
Beijing Chaoyang Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-科-591 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京朝阳医院医学伦理会 |
||
|
Name of the ethic committee: |
Ethics committee of Beijing Chaoyang Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-08-05 00:00:00 | ||
|
伦理委员会联系人: |
吕亚丽 |
||
|
Contact Name of the ethic committee: |
Lv Yali |
||
|
伦理委员会联系地址: |
工体南路8号 |
||
|
Contact Address of the ethic committee: |
Gongti South Road 8th, Chaoyang District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 85231484 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
首都医科大学附属北京朝阳医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Chaoyang Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
工体南路8号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Gongti South Road 8th, Chaoyang District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国老年和老年医学学会 |
||||||||||||||||||||||
|
Source(s) of funding: |
China association of gerontology and geriatrics |
||||||||||||||||||||||
|
研究疾病: |
牙列缺失 |
||||||||||||||||||||||
|
Target disease: |
dentition defect |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
研究义齿稳固剂对老年人活动义齿固位稳定性及生活质量的影响 |
||||||||||||||||||||||
|
Objectives of Study: |
To study the effect of denture adhesive on the stability of removable denture and the quality of life in elderly people |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1)体内植入心脏起搏器; 2)长期服用可能干扰研究方案或结果的药物(由研究者确定); 3)胰岛素依赖型糖尿病患者; 4)服用或曾服用治疗骨质疏松症的双磷酸盐药物; 5)严重的慢性疾病或放/化疗术后,需要住院治疗; 6)已知或怀疑对义齿/义齿稳固剂中相关化学成分与材料过敏; 7)正在参与其他可能影响研究方案进行及结果的临床研究; 8)近期(1年内)大量饮酒史或其他药物滥用; 9)存在听力、语言或行动障碍者 |
||||||||||||||||||||||
|
Exclusion criteria: |
1) Implantation of a pacemaker in the body; 2) Long-term administration of drugs that may interfere with the study protocol or results (determined by the investigator); 3) Patients with insulin-dependent diabetes mellitus; 4) Taking or having taken bisphosphonate drugs for the treatment of osteoporosis; 5) Severe chronic diseases or postoperative radiotherapy/chemotherapy requiring hospitalization; 6) Known or suspected allergy to the relevant chemical components and materials in dentures/denture stabilizers; 7) Participating in other clinical studies that may affect the conduct and results of the research protocol; 8) Recent (within 1 year) history of heavy alcohol consumption or other drug abuse; 9) Those with hearing, speech or mobility impairments |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-08-10 00:00:00至 To 2026-12-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-08-10 00:00:00 至 To 2025-08-10 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
准备按顺序编码、不透光的密封信封,将分组编号随机装入信封并密封。按照患者入选顺序编号并给予相应编号的信封,按照信封内的分组方案进行分组。每个受试者的保持方案由生成的随机序列决定。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Prepare a sealed envelope that is coded in sequence and opaque, and randomly put the group number into the envelope and seal it. The envelopes were numbered according to the order in which patients were selected and given corresponding numbers, and were grouped according to the grouping scheme in the envelopes. The retention scheme of each subject is determined by the generated random sequence. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
开放 |
|
Blinding: |
Open label |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
NA |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NA |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用病例记录表采集数据,使用spss管理数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection via CRF, data management via spss |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |